tiprankstipranks
Tenaya Therapeutics (TNYA)
NASDAQ:TNYA
US Market
TNYA
Tenaya Therapeutics
RESEARCH TOOLSreports

Tenaya Therapeutics (TNYA) Income Statement

3,119 Followers

Tenaya Therapeutics Income Statement

Last quarter (Q4 2025), Tenaya Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Tenaya Therapeutics's net income was $-20.18M. See Tenaya Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -8.44M$ -8.47M$ -8.69M$ -8.71M$ -4.03M
Operating Expenses
$ 84.89M$ 107.48M$ 122.51M$ 116.91M$ 68.78M
Depreciation and Amortization
$ 8.44M$ 8.47M$ 8.69M$ 8.71M$ 4.03M
EBITDA
$ -84.89M$ -102.66M$ -115.40M$ -114.95M$ -68.70M
Operating Income
$ -93.33M$ -115.95M$ -131.19M$ -125.62M$ -72.81M
Other Income/Expenses
$ 2.73M$ 4.82M$ 7.11M$ 1.96M$ 85.00K
Pretax Income
$ -90.60M$ -111.13M$ -124.08M$ -123.67M$ -72.72M
Net Income
$ -90.60M$ -111.13M$ -124.08M$ -123.67M$ -72.72M
Per Share Metrics
Basic EPS
$ -0.59$ -1.31$ -1.68$ -2.76$ -1.69
Diluted EPS
$ -0.59$ -1.31$ -1.68$ -2.76$ -1.69
Weighted Average Shares Outstanding
 152.97M 84.82M 73.79M 44.82M 41.29M
Weighted Average Shares Outstanding (Diluted)
 152.97M 84.82M 73.79M 44.82M 41.29M
Currency in USD

Tenaya Therapeutics Earnings and Revenue History